Clinical Research Directory

Inclusion Criteria: * Solid tumor patients stage 2-4. * Cancer patients who have been previously treated or shown resistance or refraction to standard-of-care therapies and where the implicated tissue has not been irradiated in the ten (10) weeks prior to excision. * Patients with tumors are amenable to biopsy or surgery for fresh tissue and blood procurement as part of routine clinical care * Patients must be referred by a healthcare professional * Willingness for tissue samples used in future research * Signed informed consent * Willingness to share diagnosis, available genetic/molecular profiling data, treatment history, and treatment outcome monitoring Exclusion Criteria: * Failure to provide informed consent * Inaccessible tumors for biopsy or unavailability of tumor tissue for research purposes * Subjects under the age of 18 * Subjects with cognitive impairment * Pregnant subjects * Contraindications to undergoing a biopsy procedure * No prior treatments, naive